Characterization of a Novel Population of Low-Density Granulocytes Associated with Disease Severity in HIV-1 Infection

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Cloke, Thomas ^a   Munder, Markus ^b   Taylor, Graham ^a   Müller, Ingrid ^a   Kropf, Pascale ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGINASE 1; CD11B ANTIGEN; CD15 ANTIGEN; CD16 ANTIGEN; CD33 ANTIGEN; CD66B ANTIGEN; LYMPHOCYTE ANTIGEN; MICROSOMAL AMINOPEPTIDASE; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL ISOLATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ANALYSIS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LEUKOCYTE COUNT; LOW DENSITY GRANULOCYTE; MALE; NORMAL DENSITY GRANULOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPIC VARIATION; PROTEIN EXPRESSION;

ADULT; ANTIGENS, CD63; ARGINASE; DISEASE PROGRESSION; GRANULOCYTES; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; PHENOTYPE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84869029312     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048939     Document Type: Article

References (23)

1. Shearer GM, Clerici M, (1991) Early T-helper cell defects in HIV infection. AIDS 5: 245-253.
2. Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, et al. (1989) Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest 84: 1892-1899.
3. Levy JA (2007) HIV and the pathogenesis of AIDS; press A, editor.
4. Appay V, Sauce D, (2008) Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 214: 231-241.
5. Bronte V, Zanovello P, (2005) Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 5: 641-654.
6. Rodriguez PC, Ochoa AC, (2008) Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev 222: 180-191.
7. Munder M, (2009) Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol 158: 638-651.
8. Youn JI, Gabrilovich DI, (2010) The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 40: 2969-2975.
9. Kropf P, Fuentes JM, Fahnrich E, Arpa L, Herath S, et al. (2005) Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. Faseb J 19: 1000-1002.
10. Ochoa AC, Zea AH, Hernandez C, Rodriguez PC, (2007) Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res 13: 721s-726s.
11. Muller I, Munder M, Kropf P, Hansch GM, (2009) Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms? Trends Immunol 30: 522-530.
12. Cloke T, Garvery L, Choi BS, Abebe T, Hailu A, et al. (2010) Increased arginase activity correlates with disease severity in HIV seropositive patients. Journal of Infectious Diseases 202: 374-385.
13. Munder M, Mollinedo F, Calafat J, Canchado J, Gil-Lamaignere C, et al. (2005) Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 105: 2549-2556.
14. Hakkert BC, Kuijpers TW, Leeuwenberg JF, van Mourik JA, Roos D, (1991) Neutrophil and monocyte adherence to and migration across monolayers of cytokine-activated endothelial cells: the contribution of CD18, ELAM-1, and VLA-4. Blood 78: 2721-2726.
15. Kuijpers TW, Hakkert BC, Hoogerwerf M, Leeuwenberg JF, Roos D, (1991) Role of endothelial leukocyte adhesion molecule-1 and platelet-activating factor in neutrophil adherence to IL-1-prestimulated endothelial cells. Endothelial leukocyte adhesion molecule-1-mediated CD18 activation. J Immunol 147: 1369-1376.
16. Kuijpers TW, Tool AT, van der Schoot CE, Ginsel LA, Onderwater JJ, et al. (1991) Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 78: 1105-1111.
17. Martin-Martin B, Nabokina SM, Blasi J, Lazo PA, Mollinedo F, (2000) Involvement of SNAP-23 and syntaxin 6 in human neutrophil exocytosis. Blood 96: 2574-2583.
18. Munder M, Schneider H, Luckner C, Giese T, Langhans CD, et al. (2006) Suppression of T cell functions by human granulocyte arginase. Blood 108: 1627-1634.
19. Elghetany MT, (2002) Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol Dis 28: 260-274.
20. Brandau S, Trellakis S, Bruderek K, Schmaltz D, Steller G, et al. (2011) Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J Leukoc Biol 89: 311-317.
21. Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, et al. (2009) Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 69: 1553-1560.
22. Modolell M, Choi B-S, Ryan RO, Hancock M, Titus RG, et al. (2009) Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis. PLoS Neglected Tropical Diseases 14: e480.
23. Haverkamp JM, Crist SA, Elzey BD, Cimen C, Ratliff TL, (2011) In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site. Eur J Immunol 41: 749-759.